TGF-β1 Induces Fibroblast Proliferation Partly Through Actibation of RaF/MEK/ERK Signaling Pathway by Inhibition of RAF-KINASE Inhibitor Protein Expression

DOI 機関リポジトリ HANDLE Web Site
  • Kambe Yuki
    Departments of Dermatology, Hirosaki University Graduate School of Medicine
  • Yamazaki Takehiko
    Departments of Dermatology, Hirosaki University Graduate School of Medicine
  • Nakano Hajime
    Departments of Dermatology, Hirosaki University Graduate School of Medicine
  • Hanada Katsumi
    Departments of Dermatology, Hirosaki University Graduate School of Medicine
  • Tamai Katsuto
    Departments of Dermatology, Hirosaki University Graduate School of Medicine
  • Tsuchida Shigeki
    Departments of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine
  • Sawamura Daisuke
    Departments of Dermatology, Hirosaki University Graduate School of Medicine

書誌事項

タイトル別名
  • TGF-β1 induces fibroblast proliferation partly through activation of Raf/MEK/ERK signaling pathway by inhibition of Raf-kinase inhibitor protein expression

この論文をさがす

説明

    The Raf-kinase inhibitor protein (RKIP) physically binds to Raf and MEK, and inhibits the Raf/MEK/ERK signaling pathway. Transforming growth factor (TGF)-β1 is a multifunctional cytokine that has a proliferative effect on fibroblasts. A considerable effort has been applied to studies of cell growth inhibition by TGF-β1, whereas far less attention has been given to the elucidation of the mechanism of TGF-β1-induced growth stimulation. In this study, we revealed that TGF-β1 significantly enhanced the proliferation of normal human dermal fibroblasts (NHDFs). In addition, we showed that TGF-β1 inhibited the expression of RKIP mRNA and protein. Moreover, a transfection experiment demonstrated that overexpression of RKIP significantly inhibited NHDF cell growth. These data point to a relationship between enhanced NHDF cell growth and reduction of RKIP expression by TGF-β1, suggesting that TGF-β1 may induce fibroblast proliferation partly through the inhibition of RKIP. Furthermore, we revealed that EGF and PDGF-BB, known activators of the Raf/MEK/ERK signal transduction pathway, failed to modulate RKIP expression. Finally, TGF-β1 induced a transient phosphorylation of ERK1/2. Although detailed mechanisms of NHDF proliferation via RKIP are yet unknown, it will be important to investigate the molecular status of RKIP in certain proliferative diseases, such as keloids, in which TGF-β1 has been reported to play a pathogenic role by inducing hyperproliferation of dermal fibroblasts.

収録刊行物

  • 弘前医学

    弘前医学 66 (2-4), 120-126, 2016

    弘前大学大学院医学研究科・弘前医学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ